Stay updated on Pembrolizumab for Refractory Esophageal Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Refractory Esophageal Cancer Clinical Trial page.

Latest updates to the Pembrolizumab for Refractory Esophageal Cancer Clinical Trial page
- Check3 days agoChange DetectedThe page now displays Revision: v3.6.4, replacing Revision: v3.6.3. This reflects a routine page update and does not alter the study information.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe page now shows Revision: v3.6.3, replacing Revision: v3.6.2 as part of a minor revision to the page's revision history.SummaryDifference0.1%

- Check32 days agoChange DetectedThe page revision label was updated from v3.6.0 to v3.6.2. This reflects a minor system/UI update rather than changes to the study details.SummaryDifference0.1%

- Check46 days agoChange DetectedThe page now indicates that recruitment is closed, and several help/navigation items were added while two formatting/version notes were removed or updated.SummaryDifference0.4%

- Check53 days agoChange DetectedNew site revision displayed as Revision: v3.5.5, replacing the previous Revision: v3.5.4. This indicates a platform update rather than changes to the study details or study content.SummaryDifference0.1%

- Check75 days agoChange DetectedThe page's revision tag was updated from Revision: v3.5.3 to Revision: v3.5.4. This reflects a minor update to the page's revision history.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab for Refractory Esophageal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Refractory Esophageal Cancer Clinical Trial page.